SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Iamarangerboy who wrote (10010)3/28/2007 10:36:34 PM
From: John Metcalf  Read Replies (1) | Respond to of 10280
 
Standard view of Merck is "not invented here syndrome". They buy research companies because the price is a rounding error, but are more reticent about operating companies.

It's been years since I've followed Merck, and the last time I looked at this aspect of their corporate culture was when they bought Sibia. Perhaps I need some updating, for which I will be grateful.



To: Iamarangerboy who wrote (10010)3/29/2007 9:39:37 AM
From: scaram(o)uche  Respond to of 10280
 
Might be number one on their list, for all I know. Are you asking a question unrelated to my post, or were you confused by my joking with rkrw??

I don't like companies that actually sell stuff, so I don't follow SEPR, other than reading the excellent commentary here, in this thread.

Best! Rick


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News